ERK inhibition or heterogeneous nuclear ribonucleoprotein K knockdown decreases cell viability, increases all‐trans retinoic acid (ATRA)‐induced differentiation in acute promyelocytic leukemia (APL) ATRA‐resistant cells, and promotes SET cleavage. This evidence concerns the gene HNRNPK and acute promyelocytic leukemia.